<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Westminster_Results"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Westminster/Results">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Westminster/Results&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Westminster/Results&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Westminster/Results&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Westminster/Results" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Westminster/Results</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2012.igem.org</H3><DIV id="wrapper"><DIV id="header"><DIV id="navigation"><UL id="navigation-list"><LI><A href="https://2012.igem.org/Team:Westminster" class="navlink">Home</A></LI><LI><A href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</A></LI><LI class="submenu-holder"><A href="https://2012.igem.org/Team:Westminster/Overview" class="navlink active">Project</A></LI><LI class="submenu-button"><A href="https://2012.igem.org/Team:Westminster/Overview" class="navlink">Overview</A></LI><LI class="submenu-button"><A href="https://2012.igem.org/Team:Westminster/Problem" class="navlink">The Problem</A></LI><LI class="submenu-button"><A href="https://2012.igem.org/Team:Westminster/Experiments" class="navlink">Experiments</A></LI><LI class="submenu-button"><A href="https://2012.igem.org/Team:Westminster/Protocols" class="navlink">Protocols</A></LI><LI class="submenu-button"><A href="https://2012.igem.org/Team:Westminster/Results" class="navlink active">Results</A></LI><LI class="submenu-button"><A href="https://2012.igem.org/Team:Westminster/Safety" class="navlink">Safety</A></LI><LI class="submenu-button"><A href="https://2012.igem.org/Team:Westminster/Journal" class="navlink">Journal</A></LI></UL><LI><A href="https://2012.igem.org/Team:Westminster/Parts" class="navlink">Parts</A></LI><LI><A href="https://2012.igem.org/Team:Westminster/Modeling" class="navlink">Modeling</A></LI><LI><A href="https://2012.igem.org/Team:Westminster/Outreach" class="navlink">Outreach</A></LI><LI><A href="https://2012.igem.org/Team:Westminster/Judging" class="navlink">Judging Criteria</A></LI><LI><A href="https://2012.igem.org/Team:Westminster/Attributions" class="navlink">Attributions</A></LI></DIV></DIV><DIV id="the-content"><DIV id="home-main-text"><H1>WIKI Notebook &amp; Results</H1><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;;color:red">PROJECT DESIGN: WEEK 1 (16 July 16 2012)</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">The first <SPAN class="GramE">criteria for the project is</SPAN>
to identify the most prevalent ALDH isoforms which have been identified in the
literature as being markers of cancer stem cells. ALDH1A1 was identified as the
most prevalent isoform and ALDH1A3 and ALDH 3A1 have also been identified. ALDH2
has been selected as a control as its expression may be up-regulated by
introducing alcohol. </SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">WEEK 2</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">This week a protocol for identifying the promoter
sequences of the ALDH isoforms has been designed. </SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">PROTOCOL</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">1. Identify the start of the protein sequence (the
promoter will be upstream of the start site). </SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">2. Locate the TATA box within the region up-stream of the
protein sequence.</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">3. Select 1000bp up-stream of the protein start site to
include the TATA box.</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">4. Compare selected promoter sequence with commercial
sequences. </SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">5. Analyse sequences for illegal sites.</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">(6. Later we identified the European Promoter Database
and compared selected sequences to sequences there and were able to select sequences
which excluded illegal sites. </SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">Primers to amplify the ALDH promoters were designed as
follows:</SPAN></P><TABLE class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"><TBODY><TR style="mso-yfti-irow:0;mso-yfti-firstrow:yes"><TD width="111" valign="top" style="width:83.4pt;border:solid windowtext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pALDH1A1-FWD</SPAN></P></TD><TD width="505" valign="top" style="width:378.7pt;border:solid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;
  font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:red">GTTTCTTCGAATTCGCGGCCGCTTCTAGAG</SPAN></B><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">CATCATATGACTTTTTTCAAC</SPAN></P><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;"><O:P> </O:P></SPAN></P></TD></TR><TR style="mso-yfti-irow:1"><TD width="111" valign="top" style="width:83.4pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pALDH1A1-RWD</SPAN></P></TD><TD width="505" valign="top" style="width:378.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;
  font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:#4F81BD;mso-themecolor:accent1">GTTTCTTCCTGCAGCGGCCGCTACTAGTA</SPAN></B><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">TTCTGATTCGGCTCCTGGAA</SPAN></P><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;"><O:P> </O:P></SPAN></P></TD></TR><TR style="mso-yfti-irow:2"><TD width="111" valign="top" style="width:83.4pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pALDH2-FWD</SPAN></P></TD><TD width="505" valign="top" style="width:378.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;
  font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:red">GTTTCTTCGAATTCGCGGCCGCTTCTAGAG</SPAN></B><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">CAGAGAAGGAAGGGAGTCTTGGTTATC</SPAN></P><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;"><O:P> </O:P></SPAN></P></TD></TR><TR style="mso-yfti-irow:3"><TD width="111" valign="top" style="width:83.4pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pALDH2-RWD</SPAN></P></TD><TD width="505" valign="top" style="width:378.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;
  font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:#4F81BD;mso-themecolor:accent1">GTTTCTTCCTGCAGCGGCCGCTACTAGTA</SPAN></B><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">CTGATGCTCCAGGTGAAGAGACC</SPAN></P><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;"><O:P> </O:P></SPAN></P></TD></TR><TR style="mso-yfti-irow:4"><TD width="111" valign="top" style="width:83.4pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pALDH1A3-FWD</SPAN></P></TD><TD width="505" valign="top" style="width:378.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;
  font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:red">GTTTCTTCGAATTCGCGGCCGCTTCTAGAG</SPAN></B><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">ATCGAGGTATAATTTATGC</SPAN></P><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;"><O:P> </O:P></SPAN></P></TD></TR><TR style="mso-yfti-irow:5"><TD width="111" valign="top" style="width:83.4pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pALDH1A3-RWD</SPAN></P></TD><TD width="505" valign="top" style="width:378.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;
  font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:#4F81BD;mso-themecolor:accent1">GTTTCTTCCTGCAGCGGCCGCTACTAGTA</SPAN></B><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">TCCCTGGCCCGAGGCGCCCTA</SPAN></P><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;
  font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:red"><O:P> </O:P></SPAN></B></P></TD></TR><TR style="mso-yfti-irow:6"><TD width="111" valign="top" style="width:83.4pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pALDH3A1-Com-FWD</SPAN></P></TD><TD width="505" valign="top" style="width:378.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;
  font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:red">GTTTCTTCGAATTCGCGGCCGCTTCTAGAG</SPAN></B><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">TATAGGCGTGAGCCACCG</SPAN></P><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;"><O:P> </O:P></SPAN></P></TD></TR><TR style="mso-yfti-irow:7"><TD width="111" valign="top" style="width:83.4pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pALDH3A1-RWD</SPAN></P></TD><TD width="505" valign="top" style="width:378.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;
  font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:#4F81BD;mso-themecolor:accent1">GTTTCTTCCTGCAGCGGCCGCTACTAGTA</SPAN></B><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">CGGCCTCGCTGATCTTGC</SPAN></P><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;"><O:P> </O:P></SPAN></P></TD></TR><TR style="mso-yfti-irow:8;mso-yfti-lastrow:yes"><TD width="111" valign="top" style="width:83.4pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pALDH3A1-Com-RWD</SPAN></P></TD><TD width="505" valign="top" style="width:378.7pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;
  font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:#4F81BD;mso-themecolor:accent1">GTTTCTTCCTGCAGCGGCCGCTACTAGTA</SPAN></B><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">GACAGAGAGCACCTGCAGCT</SPAN></P><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;"><O:P> </O:P></SPAN></P></TD></TR></TBODY></TABLE><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;"><O:P> </O:P></SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">WEEK3</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">Search for template DNA to construct experimental parts
has begun. Search of the Registry found no parts which could be used for our
design. We have contacted DTU-Denmark 2011 <SPAN class="SpellE">iGEM</SPAN> team
to obtain some of their parts directly. Parts requested from DTU are on
plasmids BBa_K678049 and BBa_K678056. <SPAN class="GramE">Serrano labs has</SPAN>
also been identified as a source of mammalian parts and MTA transfer is being
set up to allow us to receive the parts. </SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">WEEK 4</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">This week was spent designing construct 3 of our project,
the construct for selectively killing Cancer stem cells based on their
expression of ALDH. Protocols for user cloning were also studied this week. </SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">WEEK 5</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">Constructs using the DTU parts have been designed. </SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">Friday was spent at the UK team meet-up.</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">WEEK 6</SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">Protocols for the lab have been put together and orders
for reagents and consumables ordered. </SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">WEEK 7</SPAN></P><P class="MsoNormal"><SPAN class="GramE"><SPAN style="font-size:12.0pt;line-height:
115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">Design of linker primers using PHUSER
site (<A href="http://www.cbs.dtu.dk/services/PHUSER/">http://www.cbs.dtu.dk/services/PHUSER/</A>).</SPAN></SPAN><SPAN style="font-size:12.0pt;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;"> Mutagenic
primers were also designed for the DTU parts which we intend to use. </SPAN></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">Linker primers are as follows:</SPAN></P><TABLE class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"><TBODY><TR style="mso-yfti-irow:0;mso-yfti-firstrow:yes"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">ALDH
  linker- FW</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border:solid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">gggtttaau</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">gtttcttcgaattcgcggccgc</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:1"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">ALDH
  linker- RV</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">atggtggcggu</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">ttcttcctgcagcggccg</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:2"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">m-CHERRY-FW</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">accgccaccau</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">ggtgagcaagggcgagga</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:3"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">m-CHERRY-RV</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">agttcttgu</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">acagctcgtccatgccgc</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:4"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">SV-40-
  FW</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">caagaacu</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">tgtttattgcagcttata</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:5"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">SV-40-RV</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">agacatgau</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">aagatacattgatgagttt</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:6"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">HYGROMYCIN-FW</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">atcatgtcu</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">gccagcaggcagaagtatgcaaagc</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:7"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">HYGROMYCIN-RV</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">agtagttu</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">cttcctgcagcggccgct</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:8"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pSB1C3-FW</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">aaactacu</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">agtagcggccgctgcagt</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:9"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">pSB1C3-RV</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">ggtcttaau</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">ctctagaagcggccgcga</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:10"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">Neomycin-FW</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">aaacctgu</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">ggaatgtgtgtcagttag</SPAN></SPAN></P></TD></TR><TR style="mso-yfti-irow:11;mso-yfti-lastrow:yes"><TD width="168" valign="top" style="width:125.9pt;border:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt;
  padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">Neomycin-RV</SPAN></P></TD><TD width="448" valign="top" style="width:336.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt"><P class="MsoNormal" style="margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal"><SPAN class="SpellE"><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;
  color:red">agaacatgau</SPAN><SPAN style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">aagatacattgatgagtttgg</SPAN></SPAN></P></TD></TR></TBODY></TABLE><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;"><O:P> </O:P></SPAN></P><P><B>WETLAB WEEK 1 (12 September 2012)</B></P><P> After months of planning we are finally in the lab!</P><P><SPAN style="color:red">Wednesday</SPAN></P><P><SPAN style="color:red">AIM:</SPAN> The primers for
    amplification of the ALDH promoter sequences have arrived. These primers have
    the <SPAN class="SpellE">Biobrick</SPAN> overhangs. Primers were diluted to 100mM
    and working concentrations of primers was made up at 10mM. The first set of
    primers to amplify the four ALDH isoforms was set up. </P><P>PCR was set up using <SPAN class="SpellE">Pfu</SPAN> polymerase. Template used was whole cells (mammalian). Cells were thawed, spun
    down and the supernatant removed and re-suspended in 50uL DMSO. We attempted to
    amplify the following promoter sequences: ALDH1A1, ALDH2, ALDH1A3, ALDH3A1 (1)
    and <SPAN class="GramE">ALDH3A1(</SPAN>2). </P><P>The cycle conditions were as follows:</P><P>Initial denaturation at 98<SUP>0</SUP>C for 30 seconds then
    30 cycles with 98<SUP>0</SUP>C for 10 seconds, 54<SUP>0</SUP>C for 30 seconds
    (annealing) and 72<SUP>0</SUP>C for 30 seconds. Final extension was at 72<SUP>0</SUP>C
    for 10 minutes and then PCR was held at 4<SUP>0</SUP>C. </P><P><SPAN style="color:red">RESULTS: </SPAN>No bands were seen
    on the gel. </P><P><SPAN style="color:red">ANALYSIS: </SPAN>It is possible that
    the DNA template (addition of whole cells) did not become available in the
    reaction. Other cellular components during <SPAN class="SpellE">lysis</SPAN> of
    the cells may also have had an impact on the efficiency of the PCR reaction. We
    have located a protocol for crude extraction of mammalian DNA and will repeat
    the PCR using extracted DNA. </P><P>The extraction protocol was performed. (<SPAN class="GramE">see</SPAN> protocols) Sample 1 was used as DNA template in the next PCR reaction. </P><P><SPAN class="SpellE">Nanodrop</SPAN> readings were as follows:</P><P>Sample 1: 42.1ng/<SPAN style="font-family:&quot;Times New Roman&quot;">µ</SPAN>L
    with purity ration 260/280 = 1.47</P><P>Sample 2: 50.4ng/<SPAN style="font-family:&quot;Times New Roman&quot;"> µ</SPAN>L with purity ration 260/280 = 1.30</P><P>Sample 3: 46.4ng/<SPAN style="font-family:&quot;Times New Roman&quot;"> µ</SPAN>L with purity ration 260/280 = 1.28</P><P><SPAN style="color:red">Thursday</SPAN></P><P><SPAN style="color:red">AIM:</SPAN> Amplification of ALDH
    promoters. A PCR reaction was carried out as before with the same reaction mix
    and PCR conditions as Wednesday. <SPAN class="GramE">amplify</SPAN> ALDH1A1 and
    ALDH2. </P><P><SPAN style="color:red">RESULTS: </SPAN><SPAN style="color:black;">Amplification of ALDH1A1 was
    successful using the ALDH1A1-Fw and ALDH-<SPAN class="SpellE">Rv</SPAN> primers.
    The band size was as expected. ALDH 2 was also amplified using ALDH2-Fw and
    ALDH2-Rv primers. </SPAN></P><P><SPAN style="color:red">ANALYSIS: </SPAN><SPAN style="color:black;">We are pleased with developments thus
    far. Difficulties in amplification of ALDH3A1 using our the <SPAN class="GramE">ALDH3A1(</SPAN>1)
    and ALDH3A1(2) primers was anticipated. Initial analysis in selecting an
    ALDH3A1 promoter region revealed a number of different options. Additionally,
    it was difficult to find commercial sequences which matched the gene sequence
    identified in NCBI. Subsequent to ordering the primers, the Eukaryotic Promoter
    Database was discovered. Primers for the EPD experimentally designed ALDH3A1
    promoter have been ordered and will be tested when they arrive.  ALDH1A1 was initially designed to be
    quite large and also includes an illegal site. An experimentally tested ALDH1A1
    promoter has been identified on EPD. There is significant overlap between this
    EPD promoter sequence and the one we had designed. A new forward EPD designed
    primer was ordered which would give a smaller promoter and also eliminate the
    illegal site. </SPAN></P><P><SPAN style="color:black;
  &lt;p&gt;&lt;span style=" color:red="">Friday</SPAN></P><P><SPAN style="color:red"> </SPAN>We have decided to try a touchdown
    PCR reaction in order to try to amplify the other parts, particularly ALDH1A1.
    Touchdown PCR is a faster but a more crude method of amplification in
    comparison to gradient PCR. After setting up the first PCR, we realised we had
    made a mistake (Touchdown 1). A second touchdown (Touchdown 2) was set up and
    run soon after with the corrections. We managed to get bands for all four
    promotes. These were cut from the gel, gel extracted, cut with EP (and ES for
    ALDH2), ligated and transformed into competent E coli. </P><P>Touchdown 1 cycle conditions were as follows:</P><P>Initial denaturation at 98<SUP>0</SUP>C for 30 seconds then
    10 cycles with 98<SUP>0</SUP>C for 10 seconds, 62<SUP>0</SUP>C for 30 seconds
    (annealing) and 72<SUP>0</SUP>C for 1 minute 10 seconds, and annealing
    temperature decreasing by 1<SUP>0</SUP>C for each cycle. Second amplification
    cycle was 20 cycles of 98<SUP>0</SUP>C for 30 seconds, 52<SUP>0</SUP>C for 10
    seconds (annealing) and 72<SUP>0</SUP>C for 1 minute 10 seconds. Final
    extension was at 72<SUP>0</SUP>C for 10 minutes and then PCR was held at 4<SUP>0</SUP>C.
    NOTE: In the second cycle (20 cycles) denaturation time at 98<SUP>0</SUP>C
    should have been 10 seconds and annealing time should have been 30 seconds.
    This correction was included in Touchdown 2. Additionally, DNA template
    concentration was increased in Touchdown 2, by increasing the volume from 1<SPAN style="font-family:&quot;Times New Roman&quot;">µ</SPAN>L per reaction to 5<SPAN style="font-family:&quot;Times New Roman&quot;"> µ</SPAN>L per reaction</P><P><SPAN style="color:red">RESULTS: </SPAN>Spurious bands were
    obtained in the touchdown 1, but ALDH1A1 and ALDH2 were amplified.  Touchdown 2 gave good results for ALDH2.
    For ALDH 1A3 and number of bands were seen. A faint band was observed at the
    expected size and this is the band which was cut from the gel. ALDH1A1 from gel
    1, ALDH2 from gel 2 and ALDH3A1 from gel 2 were also cut from the gel and gel
    purified. Extracted DNA was run on a gel to verify the gel extraction process.  Gel extracted DNA was digested with EP
    and ALDH2 was restricted with ES. The backbone was restricted with EP and ES <SPAN class="SpellE">aswell</SPAN>. Restriction digests were saved till the next day. </P><P>GEL 1-Touchdown 1</P><P>Gel 2-Touchdown 2</P><P><B>WEEK 2</B></P><P><SPAN style="color:red">Monday</SPAN></P><P>The linker primers and the EPD primers have arrived today.  Touchdown PCR to amplify the promoter
    parts was set up. The touchdown PCR was as before. The forward <SPAN class="GramE">ALDH1A1(</SPAN>EPD) primer was paired with the reverse primer
    ALDH1A1-RV. The EPD designed primers for ALDH3A1 were tested. </P><P><SPAN style="color:red">RESULTS: </SPAN>It worked a dream!
    We have got lovely bands for <SPAN class="GramE">ALDH1A1(</SPAN>EPD), ALDH2 and
    ALDH3A1 (EPD). However the band observed for ALDH1A3 was almost twice the
    expected size. The size expected was around 900bp and the size seen on the gel
    is around 1500bp. Parts cut from the gel were ALDH1A1 (EPD), ALDH3A1 (EPD) and
    ALDH2 (<SPAN class="SpellE">Wmin</SPAN>). DNA was gel extracted and purified. DNA
    was then run on a gel to verify the extraction process. An overnight digestion
    was set up to create the <SPAN class="SpellE">Biobrick</SPAN> overhang parts. Only
    the ALDH1A3 digest from previously was kept. The other digests were discarded
    at this point. </P><P><SPAN style="color:red">Tuesday</SPAN></P><P>Today the restricted parts were cloned to the pSB1C3
    backbone and transformed to <I>E. coli.  </I>Parts cloned were the ALDH1A1 (EPD),
    ALDH2, ALDH1A3 and ALDH3A1. Transformed <I>E.
    coli </I>was plated to chloramphenicol plates which were incubated overnight at
    37<SUP>0</SUP>C.  More plated and
    broth were made up ready for use. The parts required from DTU Denmark and Serrano
    are being arranged for delivery to us. </P><P>The following promoter parts have been mad ready. </P><P>ALDH1A1 –<SPAN style="color:red">BBa_K940000</SPAN></P><P>ALDH2 –<SPAN style="color:red">BBa_K940001</SPAN></P><P>ALDH 1A3 –<SPAN style="color:red">Bba_K940002</SPAN></P><P>ALDH3A1 –<SPAN style="color:red">BBa_K940003</SPAN></P><P><SPAN style="color:red">Wednesday</SPAN></P><P>The linker primers were hydrated ready for use. We are still
    waiting for the parts from DTU and Serrano. There have been a number of issues
    with delivery but we are hoping to have them sorted and the parts delivered by
    Friday. Colony PCR was done to confirm the inserts ligated yesterday. </P><P><SPAN style="color:red">RESULTS: </SPAN>Only some of the <SPAN class="GramE">colony PCR have</SPAN> worked. This may be due to suboptimal primer
    annealing temperatures. Colony PCR was carried out as 10µL volumes an annealing
    temperature was 58<SUP>0</SUP>C using the <SPAN class="SpellE">Pfu</SPAN> polymerase. All colonies were inoculated to LB broth and grown overnight at 37<SUP>0</SUP>C
    in a shaking incubator. </P><P><SPAN style="color:red">Thursday</SPAN></P><P>Two samples of each of the LB cultures were selected and
    plasmid extracted using the <SPAN class="SpellE">QIAprep</SPAN> kit. PCR was then
    done on the extracted plasmid in order to confirm DNA insert. This was done as
    we had not managed to get good bands for <SPAN class="GramE">all the</SPAN> colony PCR’s. The PCR results were variable. Again, this may have been due to
    annealing temperatures used in PCR. The samples were analysed on the <SPAN class="SpellE">nanodrop</SPAN>. <SPAN class="SpellE">Nanodrop</SPAN> results were
    as follows:</P><P>But it has now been found that the concentrations we have
    are too low to send for sequencing and still have enough for sending to iGEM
    parts registry. An attempt to concentrate the samples was made by putting the
    samples in a spin vacuum. Disaster!!! I have mixed up the lids! Colonies were
    quickly re-picked and inoculated to LB for growth overnight. </P><P><SPAN style="color:red">Friday</SPAN></P><P>The parts have arrived from DTU Denmark. PCR has been set up
    using <SPAN class="SpellE">Pfu</SPAN> Turbo. DNA template used was as follows:</P><P>ALDH1A1 <SPAN style="color:red">(BBa_K940000) </SPAN>extracted
    plasmid</P><P><SPAN class="SpellE"><SPAN class="GramE">mCherry</SPAN></SPAN><SPAN style="color:red">(</SPAN><SPAN lang="EN" style="color:red;">BBa_K678067) </SPAN><SPAN lang="EN" style="color:black;">DTU</SPAN></P><P><SPAN lang="EN" style="color:black;">terminator </SPAN><SPAN style="color:red">(</SPAN><SPAN lang="EN" style="color:red;">BBa_K678067) </SPAN><SPAN lang="EN" style="color:black;
">DTU</SPAN></P><P><SPAN lang="EN" style="color:black;">hygromycin </SPAN><SPAN lang="EN" style="color:red;">(BBa_K678049) </SPAN><SPAN lang="EN" style="color:black;
">DTU</SPAN></P><P><SPAN lang="EN" style="color:black;">ALDH2 </SPAN><SPAN style="color:red">(BBa_K940000) </SPAN><SPAN style="color:black;">extracted plasmid</SPAN></P><P><SPAN lang="EN" style="color:black;">Neomycin </SPAN><SPAN style="color:red">(</SPAN><SPAN lang="EN" style="color:red;">BBa_K678067) </SPAN><SPAN lang="EN" style="color:black;
">DTU</SPAN></P><P><SPAN lang="EN" style="color:black;">Biobrick
    backbone </SPAN><SPAN lang="EN" style="color:red;">(pSB1C3)</SPAN><SPAN lang="EN" style="color:black;
"> unrestricted </SPAN></P><P><SPAN style="color:red">RESULTS: </SPAN>Unfortunately we did
    not get any bands. Plasmid was visible on the gels which were run. This may
    indicate that the plasmid concentration was too high for the PCR reaction. Plasmid
    extraction was done using <SPAN class="SpellE">QIAplasmid</SPAN> prep kit. PCR
    was done on the extracted plasmid, but again the PCR was not very successful.</P><P><SPAN style="color:red">NEXT STEPS: </SPAN>Plasmid template was diluted 1/1000
    and another PCR set up using the <SPAN class="SpellE">Pfu</SPAN>. <SPAN class="SpellE">Hygromycin</SPAN> is the only part which was amplified. Mg<SUP>2<SPAN class="GramE">+ <SPAN style="vertical-align:baseline"> was</SPAN></SPAN></SUP> included in the
    reaction mix this time. DTU had reported success when they used Mg<SUP>2<SPAN class="GramE">+ <SPAN style="vertical-align:baseline">.</SPAN></SPAN></SUP> We
    were able to amplify <SPAN class="SpellE">hygromycin</SPAN>. </P><P><B>WEEK 3</B></P><P><SPAN style="color:red">Monday</SPAN></P><P>The plasmid previously extracted was analysed on the <SPAN class="SpellE">nanodrop</SPAN>. The samples were made ready for sequencing and
    for sending to iGEM. </P><P><SPAN class="SpellE">Nanodrop</SPAN> results were as follows:</P><P><SPAN class="GramE">ALDH1A1(</SPAN>1): 64.5ng/<SPAN style="font-family:&quot;Times New Roman&quot;">µ</SPAN>L with purity ration 260/280 =
    2.13</P><P><SPAN class="GramE">ALDH1A1(</SPAN>2): 348.5ng/<SPAN style="font-family:&quot;Times New Roman&quot;">µ</SPAN>L with purity ration 260/280
    =2.20</P><P><SPAN class="GramE">ALDH2(</SPAN>1): 59ng/<SPAN style="font-family:&quot;Times New Roman&quot;">µ</SPAN>L with purity ration 260/280 =
    1.08</P><P><SPAN class="GramE">ALDH2(</SPAN>2): 66.8ng/<SPAN style="font-family:&quot;Times New Roman&quot;">µ</SPAN>L with purity ration 260/280 =
    1.80</P><P><SPAN class="GramE">ALDH1A3(</SPAN>2): 166.9ng/<SPAN style="font-family:&quot;Times New Roman&quot;">µ</SPAN>L with purity ration 260/280 =
    2.17</P><P><SPAN class="GramE">ADH1A3(</SPAN>2): 44.5ng/<SPAN style="font-family:&quot;Times New Roman&quot;">µ</SPAN>L with purity ration 260/280 =
    2.20</P><P><SPAN class="GramE">ADH1A3(</SPAN>2): 174.2ng/<SPAN style="font-family:&quot;Times New Roman&quot;">µ</SPAN>L with purity ration 260/280 =
    2.20</P><P><SPAN class="GramE">ADH1A3(</SPAN>2): 201.4ng/<SPAN style="font-family:&quot;Times New Roman&quot;">µ</SPAN>L with purity ration 260/280 =
    2.22</P><P>PCR using <SPAN class="SpellE">Taq</SPAN> polymerase was set
    up. We may be able to amplify the parts using this different polymerase.
    Unfortunately such products could not be used for user cloning. <SPAN class="SpellE">Taq</SPAN> PCR was set up according to manufacturer protocol. PCR
    was run overnight. </P><P><SPAN style="color:red">Tuesday</SPAN></P><P><SPAN style="color:black;">The overnight
    PCR was analysed. </SPAN></P><P><SPAN style="color:black;">Promoter
    parts were sent for sequencing. The parts were also packaged and sent to iGEM
    registry. </SPAN></P><P>ALDH1A1 –<SPAN style="color:red">BBa_K940000</SPAN></P><P>ALDH2 –<SPAN style="color:red">BBa_K940001</SPAN></P><P>ALDH 1A3–<SPAN style="color:red">Bba_K940002</SPAN></P><P>ALDH3A1 –<SPAN style="color:red">BBa_K940003</SPAN></P><P><SPAN style="color:red">Wednesday</SPAN></P><P>CONCLUSION:</P><P>Unfortunately we have not been able to achieve all that we set out
    to do in the lab. In the two and a half weeks which we have had in the lab we were
    able to amplify the promoter regions which we had designed and we have sent them to
    iGEM registry. These parts are currently being sequenced. </P><P> Parts produced by the group</P><P> ALDH1A1 promoter BBa_K940000</P><P> ALDH2  promoter  BBa_K940001</P><P> ALDH1A3 promoter BBa_K940002</P><P> ALDG3A1 promoter BBa_K940003</P><P class="MsoNormal"><B style="mso-bidi-font-weight:normal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;">Post
European Regional in Amsterdam</SPAN></B></P><P class="MsoNormal"><SPAN style="font-size:12.0pt;line-height:115%;font-family:
&quot;Arial&quot;,&quot;sans-serif&quot;">In order to test the project idea, a new approach has
been taken. Parts from Serrano will be used to construct the project plasmids
for experiment 1 and 2. Parts will be assembled using restriction-ligation. </SPAN></P></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2012.igem.org/Team:Westminster/Results">http://2012.igem.org/Team:Westminster/Results</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Westminster/Results" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Westminster/Results" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Westminster/Results&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Westminster/Results&amp;oldid=294974" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2012.igem.org:Privacy_policy" title="2012.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2012.igem.org:General_disclaimer" title="2012.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>